Raymond James Financial Inc Mirum Pharmaceuticals, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 256,612 shares of MIRM stock, worth $13.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
256,612Holding current value
$13.4 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
197Shares Held
54.3MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$344 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$234 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$180 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$169 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$161 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.92B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...